Related Experiment Videos
Neuroleptic malignant syndrome induced by metoclopramide
A Donnet1, J R Harle, J C Dumont
1Clinique de Neurologie, CHU Timone, Marseille, France.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|January 1, 1991
Abstract:
Neuroleptic malignant syndrome (NMS) associated with metoclopramide is rare. NMS probably results from neuroleptic-induced dopamine receptor blockade. We describe a case and have found only seven reports of metoclopramide-induced NMS in the literature.